News from 3-v biosciences, inc

Dec 04, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Commences Patient Dosing in Phase 1 Clinical Study of FASN Inhibitor TVB-2640 in Patients with Advanced Solid Tumors

 3-V Biosciences, Inc., a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and...

Nov 21, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Names Dr. William McCulloch Chief Medical Officer

 3-V Biosciences, Inc. (3-V), a clinical-stage biopharmaceutical company developing therapeutics that modulate key pathways in oncology and...

Oct 21, 2013, 12:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Presents Positive Data for Novel FASN Inhibitor at the AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

 3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key host-cell pathways resulting in death of tumor...

Jun 21, 2013, 08:30 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Completes $20 Million Series C Financing

3-V Biosciences, Inc., a biopharmaceutical company developing therapeutics that modulate key pathways in oncology and infectious disease, today...

Nov 10, 2012, 09:01 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Presents Positive Preclinical Data on HCV Product Candidates Targeting FASN at the American Association for the Study of Liver Disease Annual Meeting 2012

 3-V Biosciences, Inc., announced today that preclinical data for its novel fatty acid synthase (FASN) inhibitors for the treatment of chronic...

Oct 01, 2012, 09:15 ET
3-V Biosciences, Inc. logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences To Present Data on HCV Product Candidates at the American Association for the Study of Liver Disease Annual Meeting 2012

3-V Biosciences, Inc., announced today that two abstracts have been accepted for presentation at the 63rd Annual Meeting of the American...

Jul 10, 2012, 09:15 ET

3-V Biosciences To Present at the Seventh Annual JMP Securities Healthcare Conference

3-V Biosciences, Inc., announced today that George Kemble, PhD, Chief Scientific Officer, will present at the upcoming JMP Securities Healthcare...

Jun 29, 2012, 09:15 ET

3-V Biosciences Appoints Douglas I. Buckley, PhD, as Vice President of Biology

 3-V Biosciences, Inc., announced today the appointment of Douglas Buckley, PhD, as Vice President of Biology.  Dr. Buckley brings...

Jan 05, 2012, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Closes Preferred Stock Financing and Designates Novel Host-Factor Hepatitis C Program

      3-V Biosciences, Inc. announced today both the closing of a Preferred Stock financing and the designation of a novel...

Aug 15, 2011, 09:45 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Appoints George W. Kemble, PhD, as Chief Scientific Officer

3-V Biosciences, Inc. announced today the appointment of George W. Kemble, PhD as Chief Scientific Officer. "We are very pleased to have George...

Feb 10, 2011, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Promotes Stephen R. Brady to Chief Business Officer

3-V Biosciences, Inc. announced today Stephen R. Brady has been named as Chief Business Officer.   "Steve's contributions have been...

Sep 30, 2010, 09:15 ET
3-V Biosciences, Inc. Logo.  (PRNewsFoto/3-V Biosciences, Inc.)

3-V Biosciences Appoints Merdad V. Parsey, MD, PhD, as Chief Executive Officer

3-V Biosciences, Inc. announced today the appointment of Merdad V. Parsey, MD, PhD as Chief Executive Officer.   (...

Jul 20, 2010, 09:15 ET

James F. Young Joins 3-V Biosciences Board of Directors

3-V Biosciences, Inc. today announced the appointment of James F. Young, Ph.D. to its Board of Directors.   "We are very pleased to...

Jun 03, 2010, 09:15 ET

3-V Biosciences Appoints Edward M. Connor, Jr., MD, Chief Medical Officer

3-V Biosciences, Inc. announced today the appointment of Edward M. Connor, Jr., MD, as Chief Medical Officer. "Ed Connor is among the most...

May 13, 2010, 08:30 ET
A F BGRMODS, LLC INTENSAFIRE BGRMODS, LLC INTENSAFIRE

BGRMods adds PS3 IntensaFIRE to line-up. (PRNewsFoto/BGRMods, LLC)[TK]
 DULUTH, MN UNITED STATES
 05/13/2010

3-V Biosciences Expands Leadership Team, Opens New Facility and Integrates Operations

3-V Biosciences, Inc. announced today the appointment of Stephen R. Brady to the post of Vice President, Corporate Development, Strategy...

Organizations in the News

The organizations with the most activity in PR Newswire's News Room

ReportBuyer
Research and Markets
Investor-Edge